Stonehage Fleming Financial Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-5,000
| Closed | -$303K | – | 220 |
|
|
2026
Q1 | $303K | Hold |
5,000
| – | – | 0.01% | 137 |
|
|
2025
Q4 | $270K | Hold |
5,000
| – | – | 0.01% | 126 |
|
|
2025
Q3 | $226K | Hold |
5,000
| – | – | 0.01% | 130 |
|
|
2025
Q2 | $231K | Sell |
5,000
-3,658
| -42% | -$180K | 0.01% | 133 |
|
|
2025
Q1 | $528K | Hold |
8,658
| – | – | 0.02% | 80 |
|
|
2024
Q4 | $490K | Buy |
+8,658
| New | +$484K | 0.01% | 104 |
|
|
2024
Q2 | – | Sell |
-195
| Closed | -$13.5K | – | 233 |
|
|
2024
Q1 | $13.5K | Buy |
+195
| New | +$9.93K | ﹤0.01% | 157 |
|
|
2023
Q2 | – | Sell |
-195
| Closed | -$13.5K | – | 205 |
|
|
2023
Q1 | $13.5K | Hold |
195
| – | – | ﹤0.01% | 157 |
|
|
2022
Q4 | $14K | Sell |
195
-5,250
| -96% | -$396K | ﹤0.01% | 154 |
|
|
2022
Q3 | $389K | Hold |
5,445
| – | – | 0.03% | 87 |
|
|
2022
Q2 | $426K | Buy |
5,445
+195
| +4% | +$14.9K | 0.02% | 119 |
|
|
2022
Q1 | $387K | Sell |
5,250
-195
| -4% | -$13.1K | 0.01% | 127 |
|
|
2021
Q4 | $340K | Buy |
5,445
+195
| +4% | +$11.4K | 0.01% | 136 |
|
|
2021
Q3 | $318K | Hold |
5,250
| – | – | 0.01% | 136 |
|
|
2021
Q2 | $348K | Sell |
5,250
-7,150
| -58% | -$466K | 0.01% | 124 |
|
|
2021
Q1 | $783K | Hold |
12,400
| – | – | 0.03% | 92 |
|
|
2020
Q4 | $769K | Hold |
12,400
| – | – | 0.03% | 93 |
|
|
2020
Q3 | $745K | Hold |
12,400
| – | – | 0.03% | 78 |
|
|
2020
Q2 | $723K | Hold |
12,400
| – | – | 0.05% | 65 |
|
|
2020
Q1 | $691K | Hold |
12,400
| – | – | 0.03% | 74 |
|
|
2019
Q4 | $794K | Hold |
12,400
| – | – | 0.03% | 81 |
|
|
2019
Q3 | $629K | Hold |
12,400
| – | – | 0.03% | 87 |
|
|
2019
Q2 | $562K | Hold |
12,400
| – | – | 0.03% | 82 |
|
|
2019
Q1 | $592K | Sell |
12,400
-5,000
| -29% | -$249K | 0.03% | 91 |
|
|
2018
Q4 | $905K | Hold |
17,400
| – | – | 0.05% | 75 |
|
|
2018
Q3 | $1.08M | Hold |
17,400
| – | – | 0.06% | 76 |
|
|
2018
Q2 | $963K | Hold |
17,400
| – | – | 0.04% | 82 |
|
|
2018
Q1 | $1.1M | Hold |
17,400
| – | – | 0.07% | 72 |
|
|
2017
Q4 | $1.07M | Sell |
17,400
-4,150
| -19% | -$260K | 0.06% | 79 |
|
|
2017
Q3 | $1.37M | Hold |
21,550
| – | – | 0.07% | 67 |
|
|
2017
Q2 | $1.2M | Sell |
21,550
-5,250
| -20% | -$286K | 0.07% | 70 |
|
|
2017
Q1 | $1.46M | Buy |
26,800
+10,250
| +62% | +$562K | 0.09% | 83 |
|
|
2016
Q4 | $967K | Sell |
16,550
-7,150
| -30% | -$391K | 0.06% | 128 |
|
|
2016
Q3 | $1.28M | Buy |
23,700
+7,150
| +43% | +$459K | 0.08% | 104 |
|
|
2016
Q2 | $1.22M | Sell |
16,550
-29,900
| -64% | -$2.11M | 0.08% | 106 |
|
|
2016
Q1 | $2.97M | Buy |
+46,450
| New | +$2.93M | 0.19% | 53 |
|
Other funds holding BMY
Stonehage Fleming Financial Services's BMY Position: Q2 2026 in Review
Stonehage Fleming Financial Services sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 5,000 shares — an estimated $303K sold.
Stonehage Fleming Financial Services first reported a position in BMY in Q1 2016 and held it in 36 quarters. The position peaked at $2.97M in Q1 2016. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Stonehage Fleming Financial Services reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
- Stonehage Fleming Financial Services sold 5,000 Bristol-Myers Squibb shares in Q2 2026, an estimated $303K.
- Stonehage Fleming Financial Services first reported a position in Bristol-Myers Squibb in Q1 2016 and held it in 36 quarters.
- Stonehage Fleming Financial Services's Bristol-Myers Squibb position peaked at $2.97M in Q1 2016.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Stonehage Fleming Financial Services's 13F filing for Q2 2026, filed 17 Aug 2026.